{
  "id": 659138,
  "title": "Definium's LSD drug clears bar in first of two Phase 3 anxiety disorder trials",
  "url": "https://urgent.news/2026/08/12/definiums-lsd-drug-clears-bar-in-first-of-two-phase-3-anxiety",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-12T11:00:54.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/definiums-lsd-drug-clears-bar-in-first-of-two-phase-3-trials-in-anxiety-disorder/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Definium Therapeutics said Wednesday its oral LSD candidate has passed a late-stage study in generalized anxiety disorder (GAD), not even two months after reporting trial success for the same asset in a severe form of ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}